PLK1-IN-14
Product Specifications
Target
PLK
Related Pathways
Cell Cycle/Checkpoint
Bioactivity
PLK1-IN-14 (Compound Hit-4) is a selective PLK1 inhibitor with an IC50 of 22.61 pM for PLK1, and an IC50 of 0.09 nM for inhibiting the proliferation of DU-145 prostate cancer cells. It is applicable in prostate cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC203722L2V 200 µL
OTUD6B (NM_016023) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 